? Candidate: F. Joseph McClernon, Ph.D., is a Research Associate in the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center (DUMC). His primary interests are in the cognitive, behavioral and emotional effects of tobacco smoking in humans including craving, withdrawal, and cessation treatment. Trained in clinical psychology and psychophysiology, he has the immediate goals of acquiring 1) intensive training in behavioral pharmacology, 2) skills in modern neuro-imaging techniques, and 3) training in the responsible conduct of clinical research. His long-term goal is to develop a high-quality research program integrating human psychopharmacology, neuro-imaging, and treatment development. Education: Through didactics, directed readings, and literature review authorship, Dr. McClernon will gain a background in general psychopharmacology with special emphases on brain reward pathways and nicotinic acetylcholine receptor (nAChR) systems. Local and offsite tutorials in advanced functional neuro-imaging topics and behavioral pharmacology research will be conducted. Additional training in clinical research program development, grantsmanship, and ethics will also be acquired. Research: Despite intensive health education, public policy, and clinical interventions, 23% of the adult U.S. population continues to smoke, and many who quit find remaining abstinent difficult. Recent evidence suggests that the maintenance of smoking behavior and failure to remain abstinent after quitting may be due in part to prolonged disturbances of cognitive functioning following quitting in many smokers. However, the neurobiological bases of these disturbances are not well understood. Thus, in his research project, Dr. McClernon will evaluate the effects of tobacco abstinence on sustained attention-a cognitive function mediated via cholinergic pathways-using fMRI methodology. Environment: DUMC provides a unique environment in which all of Dr. McClernon's career development goals can be accomplished. He has access to 1) state-of-the-art, research-dedicated functional neuro-imaging facilities, 2) graduate level courses in pharmacology and clinical research, and 3) consultants in a broad range of fields. Dr. McClernon will continue to administer current awards and compete for additional extramural funding while he completes the goals of the application. ? ? ? ?

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
Application #
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Nemeth-Coslett, Rosemarie V
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Felder, Jennifer N; Smoski, Moria J; Kozink, Rachel V et al. (2012) Neural mechanisms of subclinical depressive symptoms in women: a pilot functional brain imaging study. BMC Psychiatry 12:152
Bidwell, L Cinnamon; Garrett, Melanie E; McClernon, F Joseph et al. (2012) A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults. Nicotine Tob Res 14:229-33
Van Voorhees, Elizabeth E; Mitchell, John T; McClernon, F Joseph et al. (2012) Sex, ADHD symptoms, and smoking outcomes: an integrative model. Med Hypotheses 78:585-93
Addicott, Merideth A; Baranger, David A A; Kozink, Rachel V et al. (2012) Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: a preliminary study. Psychopharmacology (Berl) 219:563-73
McClernon, F Joseph; Van Voorhees, Elizabeth E; English, Joe et al. (2011) Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res 13:784-92
Bidwell, L Cinnamon; McClernon, F Joseph; Kollins, Scott H (2011) Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav 99:262-74
Froeliger, Brett; Kozink, Rachel V; Rose, Jed E et al. (2010) Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. Psychopharmacology (Berl) 210:577-83
Kozink, Rachel V; Lutz, Avery M; Rose, Jed E et al. (2010) Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. Addict Biol 15:480-90
Kollins, Scott H; McClernon, F Joseph; Van Voorhees, Elizabeth E (2010) Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol 18:221-8
Kozink, Rachel V; Kollins, Scott H; McClernon, F Joseph (2010) Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control. Neuropsychopharmacology 35:2600-6

Showing the most recent 10 out of 28 publications